Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures–2019 update: cosponsored …

JI Mechanick, C Apovian, S Brethauer… - Surgery for Obesity and …, 2020 - Elsevier
Objective The development of these updated clinical practice guidelines (CPG) was
commissioned by the American Association of Clinical Endocrinologists, The Obesity …

Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of …

J Neuberger, J Patel, H Caldwell, S Davies, V Hebditch… - Gut, 2020 - gut.bmj.com
Liver biopsy is required when clinically important information about the diagnosis, prognosis
or management of a patient cannot be obtained by safer means, or for research purposes …

Gut microbiome-based machine learning for diagnostic prediction of liver fibrosis and cirrhosis: a systematic review and meta-analysis

X Liu, D Liu, C Tan, W Feng - BMC Medical Informatics and Decision …, 2023 - Springer
Background Invasive detection methods such as liver biopsy are currently the gold standard
for diagnosing liver cirrhosis and can be used to determine the degree of liver fibrosis and …

Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis

S Xin, Q Zhan, X Chen, J Xu, Y Yu - BMC gastroenterology, 2020 - Springer
Background Nonalcoholic steatohepatitis (NASH) is a key turning point during the
progression of nonalcoholic fatty liver disease (NAFLD). Recent studies have shown that …

Muscle fat contents rather than muscle mass determines nonal coholic steatohepatitis and liver fibrosis in patients with severe obesity

E Han, MK Kim, HW Lee, S Ryu, HS Kim, BK Jang… - …, 2022 - Wiley Online Library
Objective This study aimed to investigate the association of muscle fat contents,
nonalcoholic steatohepatitis (NASH), and liver fibrosis in patients with severe obesity …

The first survey addressing patients with BMI over 50: a survey of 789 bariatric surgeons

M Kermansaravi, P Lainas, SS Shahmiri, W Yang… - Surgical …, 2022 - Springer
Background Bariatric surgery in patients with BMI over 50 kg/m2 is a challenging task. The
aim of this study was to address main issues regarding perioperative management of these …

Evaluation of a micro-spectrometer for the real-time assessment of liver graft with mild-to-moderate macrosteatosis: A proof of concept study

N Golse, C Cosse, MA Allard, A Laurenzi… - Journal of …, 2019 - Elsevier
Background & Aims Liver macrosteatosis (MS) is a major predictor of graft dysfunction after
transplantation. However, frozen section techniques to quantify steatosis are often …

Myosteatosis predicts bariatric surgery response: A longitudinal study in patients with morbid obesity

E Han, MK Kim, HW Lee, S Ryu, HS Kim… - The Journal of …, 2024 - academic.oup.com
Context Data on the preoperative factors for bariatric surgery response in patients with
morbid obesity are limited, and there are no studies on the relationship between …

[HTML][HTML] Prognostic Characteristics of Metabolic Dysfunction-Associated Steatotic Liver in Patients with Obesity Who Undergo One Anastomosis Gastric Bypass …

S Crommen, KP Rheinwalt, A Plamper, D Rösler… - Nutrients, 2024 - mdpi.com
Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is
closely associated with obesity and insulin resistance (IR). Identifying characteristics that …

Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity

D Meneses, A Olveira, R Corripio… - … , diabetes y nutricion, 2022 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in morbid obesity
(MO). A considerable proportion of patients with MO have non-alcoholic steatohepatitis …